idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store

Veranstaltung


institutionlogo

21.01.2021 - 22.01.2021 | Hannover

Models of Lung Disease 2021 – Special Edition »Corona«

“Models of Lung Disease” 2021 aims to bring together different stakeholders from industry and academia and to provide a highly interactive platform for exchanging ideas and findings in translational lung research. This special edition will focus on different aspects of SARS-CoV-2: virology, immunology, clinical development, prevention and epidemiology, and development of drugs for COVID-19 patients.

Due to the COVID-19 pandemic, “Models of Lung Disease” has moved into the virtual world, combining pre-recorded presentations with an exciting interactive conference format, hosted on January 21 and 22, 2021.

Target group and topics
In the tradition of this series of seminars, Models of Lung Disease 2021 aims to bring together different stakeholders from industry and academia and to provide a highly interactive platform for exchanging ideas and findings in translational lung research. This special edition will focus on different aspects of SARS-CoV-2: virology, immunology, clinical development, prevention and epidemiology, and development of drugs for COVID-19 patients. In addition to live lectures and pre-recorded poster presentations, this virtual conference will provide ample opportunities for interaction between participants, both in small groups and 1:1 chat rooms.

Posters
Scientific posters are an important constituent of the seminar Models of Lung Disease 2021. A poster prize will be awarded for the best three posters presented during this event. Poster authors are kindly asked to submit an abstract by December 16, 2020, and to carefully read the "Information for poster authors" on our XING Events website for more detailed information. Please note that abstracts can be accepted only if at least one author of the poster has registered for the seminar.

Program
Preliminary program (subject to change without notice):

Thursday, January 21, 2021
13.00 Welcome
Armin Braun, Fraunhofer ITEM, Germany

Session 1: Understanding clinical aspects of COVID-19

13:15 The clinical picture of COVID-19
Tobias Welte, Hannover Medical School/German Center for Lung Research (Germany)

13.45 COVID-19 – a comprehensive approach
Danny Jonigk, Hannover Medical School (Germany)

14.15 Exploiting the AOP framework to organize human evidence and understand COVID-19 disease progression
Kristie Sullivan, Physicians Committee for Responsible Medicine (USA)

14.45 Coffee break (theme groups)

Session 2: Exposure to SARS-CoV-2 and imaging of the lung

15.15 Exposure to SARS-COV-2: the role of aerosols
Katharina Schwarz, Fraunhofer ITEM

15.45 Multiscale lung imaging of lethal COVID-19 pneumonia using synchrotron radiation-based CT
Christian Dullin, University Medical Center Göttingen (Germany)

16:15 CT-based assessment of COVID-19
Bianca Lassen-Schmidt, Fraunhofer MEVIS (Germany)

16.45 Coffee break (free networking)

Poster Session

17.15 Poster discussions (parallel breakout sessions)
18.15 Results from the poster breakout sessions
18.30 Awarding of poster prizes



Friday, January 22, 2021
Session 3: Understanding SARS-CoV-2 infection and early drug development

13.00 TBD
N.N.

13.30 SARS-CoV-2 entry into cells and its inhibition
Stefan Pöhlmann, German Primate Center/University of Göttingen (Germany)

14.00 Repurposing of approved drugs as inhibitors of SARS-CoV-2 spike/ACE2 interaction with in vitro antiviral activity
Benjamin Bailly, Griffith University, Gold Coast (Australia)

14.30 Coffee break ( (theme groups)

Session 4: Development of (inhaled) drugs against SARS-CoV-2

15.00 Pulmonary treatment and nonclinical models of COVID-19
Jacob (Jake) McDonald, Lovelace Biomedical (USA)

15.30 The Fraunhofer response to COVID-19: from screening to preclinical development
Armin Braun, Fraunhofer ITEM

16.00 Fast track antibody development against COVID-19
Thomas Schirrmann, YUMAB/CORAT Therapeutics (Germany)

16.30 Coffee break (free networking)

17.00 Wrap-up and final discussion

Hinweise zur Teilnahme:
Virtual conference.

Language: Englisch

Costs:
150 euros per participant (until January 10, 2021)
200 euros per participant in case of late registration after January 10, 2021

Termin:

21.01.2021 ab 13:00 - 22.01.2021 17:30

Anmeldeschluss:

21.01.2021

Veranstaltungsort:

virtual (Hannover)
30625 Hannover
Niedersachsen
Deutschland

Zielgruppe:

Journalisten, Wissenschaftler

Relevanz:

international

Sachgebiete:

Medizin

Arten:

Konferenz / Symposion / (Jahres-)Tagung, Seminar / Workshop / Diskussion

Eintrag:

15.12.2020

Absender:

Dr. Cathrin Nastevska

Abteilung:

Kommunikation

Veranstaltung ist kostenlos:

nein

Textsprache:

Englisch

URL dieser Veranstaltung: http://idw-online.de/de/event67557


Hilfe

Die Suche / Erweiterte Suche im idw-Archiv
Verknüpfungen

Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

Klammern

Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

Wortgruppen

Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

Auswahlkriterien

Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).